SAN DIEGO (AP) — SAN DIEGO (AP) — Cardiff Oncology, Inc. (CRDF) on Thursday reported a loss of $12.3 million in its first quarter.
On a per-share basis, the San Diego-based company said it had a loss of 18 cents.
The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.
The molecular diagnostic company posted revenue of $41,000 in the period, which also missed Street forecasts. Three analysts surveyed by Zacks expected $136,000.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/CRDF
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
